Firefly Neuroscience, Inc. (AIFF) stock
Close on Nov 11, 2026Market cap $16.32MP/E –Yield –
Firefly Neuroscience, Inc. grew revenue 162.8% to $2.06M over the twelve months to Sep 30, 2026. At the latest close the market valued the company at $16.32M.
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Sep 30, 2026
Valuation
- Market cap
- $16.32M
- P/E ratio
- –
- Price to sales
- 7.93
- Price to book
- 1.22
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Revenue
- $2.06M
- Net income
- -$7.95M
- EPS, diluted
- -$0.50
- Book value per share
- $0.62
- Diluted shares
- 22M
Trading
- Previous close
- $0.98
- Open
- $0.99
- Day's range
- $0.99 – $1.05
- Volume
- 63,430
- Average volume (20 days)
- 88,378
- Beta (5 years)
- 1.45
- 52-week range
- $0.62 – $3.15
- RSI (14 days)
- 49.5
- Volatility (1 year)
- 203.8%
- Relative volume
- 0.03×
- WACC
- 12.1%
Market cap history
Month-end market cap since 2011, using shares outstanding reported at the time
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 11, 2026. The S&P 500 is measured by the SPY fund.
| Period | AIFF | S&P 500 | Difference | AIFF per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -12.6% | -2.4% | −10.2 pts | ||
| 3 months | -8.8% | -1.2% | −7.6 pts | ||
| Year to date | +18.9% | +12.3% | +6.6 pts | ||
| 1 year | -37.0% | +12.4% | −49.4 pts | ||
| 3 years | -72.9% | +78.8% | −151.7 pts | -35.3% | +21.4% |
| 5 years | -98.9% | +75.2% | −174.0 pts | -59.3% | +11.9% |
| 10 years | -76.9% | +311.1% | −388.0 pts | -13.6% | +15.2% |
Fifteen years at a glance
Fiscal years 2011 to 2025 and trailing twelve months, USD
Revenue
Gross profit
Operating income
Net income
EPS, diluted
Free cash flow
Press releases
Releases Firefly Neuroscience filed with the SEC as exhibits to Form 8-K or 6-K
- Update
- Results
- Results
- Update
- Update
- Update
About Firefly Neuroscience
Services-Prepackaged Software
Firefly Neuroscience, Inc. is an artificial intelligence medical technology company specializing in neurodiagnostics and clinical decision-support. Through its integrated Firefly Platform and FDA-cleared Evoke System, the company combines specialized hardware, cloud-based analytics, and an extensive electrophysiological database. Its technology captures and analyzes standardized electroencephalographic (EEG), event-related potential (ERP), and heart rate variability data to generate structured clinical reports. The platform serves healthcare providers, psychiatric practices, neurology offices, behavioral health clinics, and pharmaceutical partners conducting clinical trials.
Company profile, executives and historyFirefly Neuroscience stock: common questions
What is Firefly Neuroscience's stock price?
AIFF closed at $1.04 on Nov 11, 2026, up 6.51% on the day. Over the past 52 weeks it traded between $0.62 and $3.15.
What is Firefly Neuroscience's market cap?
Firefly Neuroscience was worth $16.32M at the close on Nov 11, 2026: the share price times the diluted shares outstanding.
What is AIFF's P/E ratio?
Firefly Neuroscience lost money over the twelve months to Sep 30, 2026 (diluted EPS -$0.50), so it has no meaningful P/E ratio.
How much revenue does Firefly Neuroscience make?
Firefly Neuroscience reported revenue of $2.06M for the twelve months to Sep 30, 2026, up 162.8% from a year earlier.
Does Firefly Neuroscience pay a dividend?
No. Firefly Neuroscience has not paid a cash dividend over the last twelve months.
How has AIFF stock performed over the past year?
Including dividends, AIFF returned -37.0% over the past year, against +12.4% for the S&P 500.
How many AIFF shares are sold short?
1M shares were sold short at the latest FINRA report, 3.99% of the float, or 5.3 days of average trading volume.
Who are Firefly Neuroscience's competitors?
Companies most similar to Firefly Neuroscience by business, industry and size include SPAI, SKKY, ZENA, VIIQ, AUID.
See a number that looks wrong?